ipilimumab   Click here for help

GtoPdb Ligand ID: 6888

Synonyms: MDX-010 | MDX-101 | MDX-CTLA-4 | Yervoy®
Approved drug Immunopharmacology Ligand
ipilimumab is an approved drug (FDA and EMA (2011))
Compound class: Antibody
Comment: Ipilimumab is an anti-CTLA-4 monoclonal antibody. It is likely the subject of patent WO2001014424 [4], as antibody 10D1 which was investigated further, claimed in patent EP1503794 [1]. Ipilimumab is an immune checkpoint inhibitor.
Click here for help
Classification Click here for help
Compound class Antibody
Ligand families/groups Immune checkpoint modulators
Approved drug? Yes (FDA and EMA (2011))
International Nonproprietary Names Click here for help
INN number INN
8568 ipilimumab
Synonyms Click here for help
MDX-010 | MDX-101 | MDX-CTLA-4 | Yervoy®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 180
Other databases
GtoPdb PubChem SID 178103470
PubChem SID 178103470
Search PubMed clinical trials ipilimumab
Search PubMed titles ipilimumab
Search PubMed titles/abstracts ipilimumab
Wikipedia Ipilimumab